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Introduction
Leptin, the protein of the ob gene produced by
adipocytes,1 regulates body weight, especially the
appetite, through negative feedback control on the
satiety center. Maternal body mass (e.g. the product of
conception, blood volume, breasts, adipose tissue, and
extracellular fluid as well as other organs) changes
considerably during pregnancy. Adipose tissues,
including subcutaneous fat and omentum, are the main
source of leptin in both nonpregnant2 and pregnant
women. During pregnancy, there is additional secretion
of leptin from the placenta, as shown by the presence of
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leptin in the cytoplasm of syncytiotrophoblast cells.3,4
Other than the adipose tissues and placenta, leptin
can also be secreted by fetal tissue, gastric mucosa, he-
patic stellate cells,5 and mammary epithelial cells.6
Theoretically, maternal adaptation during pregnancy
makes great changes in serum leptin levels, although
conflicting results have been found in studies of the
placental secretion of leptin during pregnancy.7
Body mass index (BMI) is related to body weight
as well as serum leptin in nonpregnant women.3
Theoretically, BMI is related to maternal serum leptin
due to the increase in maternal body weight that
occurs with increasing gestational age (GA). However,
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Masuzaki et al3 reported conflicting results.
The relationships between maternal serum leptin
and GA have been reported by Harigaya et al8 and
Gòmez et al.9 Their studies, which focused on the later
half of pregnancy only, demonstrated statistical
significance between maternal serum leptin and GA.
Other studies also reported changes in leptin level
during pregnancy,10–13 but only a few focused on the
relationship between maternal serum leptin and the
whole gestational course. This study was designed to
determine the interrelationships of maternal serum
leptin and BMI with GA.
Methods
Study population
Blood samples were obtained with consent from women
with a normal singleton pregnancy at prenatal visits for
registration, Down syndrome screening test, 50 g
glucose challenge test, hepatitis B markers test, and
near or at the time of delivery. Maternal blood samples
were drawn during the day, when possible, to avoid
the effect of diurnal changes in serum leptin
concentration.14 Serum samples were collected from
blood samples spun at 4,000g for 10 minutes and were
stored at –20°C until assay.
The expected date of delivery was calculated from the
first day of the last menstrual period. When no reliable
menstrual dates were available or menstrual cycles were
irregular, ultrasound calculations, especially early ultra-
sound measurements, were used to date the pregnancy.
Maternal characteristics including height, body
weight and GA at each blood test were recorded, as
well as the time of delivery.
Leptin assay
Serum concentrations of leptin were measured using
the ACTIVETM Human Leptin immunoradiometric
assay (IRMA; Diagnostic Systems Laboratories Inc,
Webster, TX, USA) in the Department of Nuclear
Medicine. The procedure employs a 2-site IRMA
principle described by Miles et al.15 The IRMA is a non-
competitive assay in which the analyte (recombinant
human leptin) to be measured is “sandwiched” between
2 antibodies. The first antibody is immobilized to the
inside walls of the tubes while the other antibody is
radiolabeled (125I-labeled anti-leptin) for detection. The
analyte present in the unknowns, standards and controls
is bound by both antibodies to form a sandwich complex.
Unbound reagents are removed by decanting and
washing the tubes. The minimal detectable concentration
of leptin was 0.10 ng/mL. The intra- and inter-assay
coefficients of variation were 3.7% and 5.2%, respectively.
Statistical analysis
Linear regression analysis and quadratic regression
analysis were used to determine the curve and the
significance of differences between the data of
continuous variables. One-way ANOVA and post hoc
tests were used to analyze leptin data between groups.
Statistical analysis was carried out with SPSS version
10.0 for Windows (SPSS Inc, Chicago, IL, USA), and
a p value of less than 0.05 was considered significant.
Results
There were 374 blood samples obtained in this study.
In the first trimester, 45 blood samples were collected.
The range of maternal serum leptin was 6.82–58.59
ng/mL and showed a correlation to body weight
(p = 0.004, r = 0.463) and BMI (p = 0.002, r = 0.491),
but not to GA (p = 0.552). Correlation was also found
between maternal BMI and body weight (p < 0.001,
r = 0.851), but neither BMI nor body weight was
related to GA (p = 0.404 and 0.097, respectively)
(Table 1).
Table 1. Interrelationships of maternal serum leptin, body mass index (BMI), body weight (BW), and gestational age (GA)
in the 3 trimesters and the whole pregnancy
First trimester Second trimester Third trimester Whole pregnancy
p r p r p r p r
Leptin vs BW 0.004 0.463 < 0.001 0.570 0.007 0.275 < 0.001 0.515
Leptin vs BMI 0.002 0.491 < 0.001 0.598 0.007 0.274 < 0.001 0.536
Leptin vs GA 0.552 0.091 0.021 0.158 0.011 0.237 0.001 0.179
BMI vs GA 0.404 0.143 < 0.001 0.377 0.053 0.199 < 0.001 0.515
BW vs GA 0.097 0.281 < 0.001 0.368 0.039 0.212 < 0.001 0.536
BMI vs BW < 0.001 0.851 < 0.001 0.891 < 0.001 0.877 < 0.001 0.911
Values compared using linear regression analysis.
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In the second trimester, there were 213 blood
samples. The range of maternal serum leptin was 2.18–
90.94 ng/mL, which not only correlated to body
weight (p < 0.001, r = 0.570) and BMI (p < 0.001,
r = 0.598), but also to GA (p = 0.021, r = 0.158)
(Figure 1). A strong correlation was found between
maternal BMI and body weight (p < 0.001, r = 0.891).
Both maternal BMI and body weight were also
correlated to GA (BMI, p < 0.001, r = 0.377; body
weight, p < 0.001, r = 0.368) (Table 1 and Figure 2).
A total of 116 blood samples were obtained in the
third trimester. The range of maternal serum leptin
was 2.70–79.36 ng/mL and was correlated to both
body weight (p = 0.007, r = 0.275) and BMI (p = 0.007,
r = 0.274). However, maternal leptin was inversely
correlated to GA (p = 0.011, r = 0.237) (Figure 3).
Maternal body weight was related to BMI (p < 0.001,
r = 0.877) and GA (p = 0.039, r = 0.212), but no
correlation was found between maternal BMI and GA
(p = 0.053, r = 0.199) (Table 1).
Throughout the pregnancy, maternal leptin level
was not only related to body weight (p < 0.001, r =
0.515) and BMI (p < 0.001, r = 0.536) (Table 1),
but also to GA (p = 0.001, r = 0.179) (Figure 4).
In addition, the relationship between leptin and GA
revealed a curve when compared by quadratic regression
analysis (p = 0.0001, r = 0.216) (Figure 5). Both
maternal body weight and BMI were related to GA
(body weight, p < 0.001, r = 0.536; BMI, p < 0.001,
r = 0.515) (Figure 6). A significant correlation was
found between maternal BMI and body weight
(p < 0.001, r = 0.911) (Table 1).
Figure 1. Relationship between maternal serum leptin and
gestational age (GA) in the second trimester (linear regression
analysis).
Figure 2. Relationship between maternal body mass index
(BMI) and gestational age (GA) in the second trimester (linear
regression analysis).
Figure 3. Relationship between maternal serum leptin and
gestational age (GA) in the third trimester with a significant
downward slope (linear regression analysis).
Figure 4. Relationship between maternal serum leptin and
gestational age (GA) throughout pregnancy (linear regression
analysis).
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Blood samples were divided into 6 groups according
to the time they were taken: less than 13, 13–20, 21–
24, 25–28, 29–36, and 37–42 weeks of gestation.
Leptin levels increased with GA and peaked in the early
third trimester (29–36 weeks of gestation), then fell
significantly in the last month of pregnancy (Figure 7).
This is compatible with the fit curve for the comparison
of leptin levels and GA by quadratic regression analysis
(Figure 5). Significant relationships were found among
leptin groups compared by 1-way ANOVA and post hoc
tests (p < 0.001) (Table 2).
Discussion
Significant correlation was found in this study between
GA and maternal serum leptin levels, which was similar
to the study of Tamas et al in 1998.16 The present
Figure 5. Relationship between maternal serum leptin and
gestational age (GA) (quadratic regression analysis).
Figure 6. Relationship between maternal body mass index (BMI) and
gestational age (GA) throughout pregnancy (linear regression analysis).
Figure 7. Median maternal serum leptin levels at various periods of
gestation graphed with an error bar showing 95% confidence interval.
study, however, differs from Tamas et al’s study in 3
aspects. The first difference was in sample size: in our
study, 374 samples were collected from 114 pregnant
women while the Tamas et al study included only 9
cases with repeated blood testing. Secondly, significant
correlation was found between maternal serum leptin
and GA throughout pregnancy in our study but was
only found prior to the 28th week in Tamas et al’s
study. Thirdly, in our study, the relationships between
maternal leptin and GA were evaluated separately in
the 3 trimesters to reveal different significances.
Similar studies of maternal serum leptin levels during
pregnancy were reported by Schubring et al,10 Sattar et
al,11 Sivan et al,12 and Hardie et al.13 Blood samples were
taken at skipped gestational ages in these studies where
changes in maternal serum leptin levels during pregnancy
were less evident. Consequently, the results were different
from this study. The sample size in our study, however,
was large enough to cover the whole of gestation and
therefore provided a highly reliable result.
Masuzaki et al3 and Sivan et al12 found no correlation
between maternal serum leptin and maternal BMI. In
our study, however, maternal BMI was not only correlated
to body weight and GA, but also related to maternal
serum leptin concentration. These different results may
arise from different sample sizes as well as methodology.
Nausea and vomiting are commonly seen in
pregnant women during the first trimester. Although
only a small portion of them gain weight, it is not
uncommon for them to experience weight loss. As a
result, apparent change in average body weight is rare.
In this study, GA was not correlated to maternal body
weight and BMI in the first trimester. Therefore, there
was no significant correlation between maternal serum
leptin level and GA during early pregnancy.
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The appetite of most pregnant women increases
after the fourth month of gestation when symptoms of
nausea and vomiting disappear.17 Therefore, in addition
to uterine content, systemic organs including sub-
cutaneous adipose tissue, omentum, blood volume
and breasts increase in size with advancing gestation.
Leptin is one of the proteins produced by syncy-
tiotrophoblasts in the placenta.3,4 Theoretically, the
amount of leptin synthesized by the placenta should
increase due to the increased size of the placental mass
with advancing gestation. However, Henson et al7 have
reported that leptin receptors in the placenta show no
apparent changes and local leptin mRNA declines with
increased GA. In the study of Yura et al,18 leptin
secretion from chorionic tissue in the first trimester was
approximately 50-fold greater than that of term placen-
tal tissue. However, other than placenta and adipose tis-
sue, leptin can be synthesized by mammary epithelial
cells,6 fetal tissue, gastric mucosa, and hepatic stellate
cells.5 With the additional increase in leptin in these
organs, significant changes in serum leptin levels related
to GA were found in the second trimester.
Serum leptin levels peaked early in the third
trimester. This finding was in agreement with Tamas
et al’s study.16 Tamas et al found no significant
correlation between maternal serum leptin and GA in
the third trimester. In the study of Schubring et al,10
leptin levels peaked at term (38–40 weeks). The
difference from our results was because parts of the
gestational period were skipped when blood samples
were collected. In our study, with advancing GA,
maternal leptin levels decreased significantly in spite of
a rapid increase in fetal weight during the third trimester.
Meanwhile, maternal body weight (p = 0.039) and
BMI (p = 0.053) were not related simultaneously to
GA, since the effect of mobilization of maternal
stored fat during earlier pregnancy could support the
energy requirements of the rapidly growing fetus.12
As a result, not only did maternal fat mass begin to
decrease at this stage, but the secretion of leptin was
also affected.
In conclusion, maternal serum leptin concentration
throughout the pregnancy course correlates not only to
body weight and BMI but also to GA. There is no
significant relationship between maternal serum leptin
and GA in the first trimester. Maternal serum leptin is
correlated to GA in the second trimester but is inversely
related to GA in the third trimester. The concentration
of maternal serum leptin peaks in the early third trimester
and declines significantly thereafter. Maternal BMI is
related to GA in the second trimester and the whole
pregnancy, but not in the first and third trimesters.
Table 2. Multiple comparisons of maternal serum leptin at various gestational ages
GA (I) GA (J) Mean difference (I – J) SE p
95% CI
Lower bound Upper bound
1 2 –3.6370 2.9135 0.213 –9.3663 2.0923
3 –4.3657 3.0888 0.158 –10.4398 1.7083
4 –10.2244* 2.8863 < 0.001 –15.9002 –4.5486
5 –15.4293* 3.2840 < 0.001 –21.8871 –8.9715
6 –6.9180* 2.9514 0.020 –12.7218 –1.1141
2 3 –0.7287 2.7141 0.788 –6.0658 4.6083
4 –6.5874* 2.4811 0.008 –11.4664 –1.7084
5 –11.7923* 2.9342 < 0.001 –17.5623 –6.0222
6 –3.2810 2.5566 0.200 –8.3084 1.7464
3 4 –5.8587* 2.6848 0.030 –11.1383 –0.5791
5 –11.0635* 3.1084 < 0.001 –17.1760 –4.9510
6 –2.5522 2.7547 0.355 –7.9693 2.8648
4 5 –5.2049 2.9072 0.074 –10.9218 0.5120
6 3.3064 2.5255 0.191 –1.6599 8.2728
5 6 8.5113* 2.9719 0.004 2.6672 14.3553
*p < 0.05. Values compared using ANOVA and post hoc test.
1 = GA < 13 weeks; 2 = 12 weeks < GA < 21 weeks; 3 = 20 weeks < GA < 25 weeks; 4 = 24 weeks < GA < 29 weeks; 5 = 28 weeks <
GA < 37 weeks; 6 = GA > 36 weeks. CI = confidence interval; GA = gestational age; SE = standard error.
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